oxidopamine has been researched along with Intraocular Pressure in 1 studies
Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).
Intraocular Pressure: The pressure of the fluids in the eye.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Talusan, E | 1 |
| Schwartz, B | 1 |
| Mandell, AI | 1 |
| Schwartz, AL | 1 |
| Alper, MG | 1 |
| Helfgott, M | 1 |
1 other study available for oxidopamine and Intraocular Pressure
| Article | Year |
|---|---|
6-hydroxydopamine in the treatment of open-angle glaucoma.
Topics: Adult; Aged; Conjunctiva; Drug Therapy, Combination; Epinephrine; Female; Glaucoma, Open-Angle; Huma | 1981 |